Jones Financial Companies
SANA icon

Jones Financial Companies’s Sana Biotechnology SANA Stock Holding History

Jones Financial Companies’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Sell
5,649
-3,519
-38% -$11.3K ﹤0.01% 3521
2026
Q1 		$25.4K Sell
9,168
-10
-0.1% -$39 ﹤0.01% 3201
2025
Q4 		$37.4K Buy
9,178
+1,655
+22% +$7.41K ﹤0.01% 2661
2025
Q3 		$25.1K Buy
7,523
+1,355
+22% +$4.9K ﹤0.01% 2677
2025
Q2 		$17.3K Hold
6,168
– – ﹤0.01% 2664
2025
Q1 		$10.5K Hold
6,168
– – ﹤0.01% 2676
2024
Q4 		$10.1K Buy
+6,168
New +$18.4K ﹤0.01% 2525

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marex Group
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Jones Financial Companies's SANA Position: Q2 2026 in Review

Jones Financial Companies reduced its Sana Biotechnology (SANA) stake by 38% in Q2 2026, selling an estimated $11.3K and leaving 5,649 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3521.

Jones Financial Companies first reported a position in SANA in Q4 2024 and has held it in 7 quarters since. The position peaked at $37.4K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Jones Financial Companies held 5,649 shares of Sana Biotechnology worth $19.3K as of Q2 2026.
  • Jones Financial Companies sold 3,519 Sana Biotechnology shares in Q2 2026, an estimated $11.3K.
  • Sana Biotechnology made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3521 holding.
  • Jones Financial Companies first reported a position in Sana Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • Jones Financial Companies's Sana Biotechnology position peaked at $37.4K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.